Related Articles
Effects of a concurrent chemoradiotherapy with S-1 for locally advanced oral cancer
Alternate‑day administration of S‑1 for elderly patients with advanced non‑small‑cell lung carcinoma: A prospective feasibility study
Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S‑1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest
Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells
Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain